يستعمل دواء ريميكاد 100مجم امبول 10ملremicade 100 mg pd. vial for i.v. inf. 10 ml tumor necrosis factor tumor necrosis factor

infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (tnf-alpha) and is used to treat autoimmune diseases. -infliximab was approved by the u.s. food and drug administration (fda) for the treatment of crohn s disease ulcerative colitis psoriasis psoriatic arthritis ankylosing spondylitis and rheumatoid arthritis. it is used off-label outside its fda approval for beh�et s disease and other conditions. infliximab is administered by intravenous infusion typically at six- to eight-week intervals.